Answers are grounded in this paper and cite their sources.
Varivax III is a live attenuated vaccine against varicella zoster virus (VZV). We report a case of recurrent vaccine-strain herpes zoster in an immunocompetent 2-year-old child. Vaccine-strain VZV was identified through polymerase chain reaction. This report aims to alert physicians that recurrent vaccine-strain herpes zoster can be a rare complication of VZV vaccination in apparently immunocompetent hosts.
No takes yet. Share an insight, caveat, or question.
Ota et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: